PMC:7161517 / 24319-24453
Annnotations
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T69 | 99-102 | Body_part | denotes | RAS | http://purl.obolibrary.org/obo/UBERON_0018229 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T111 | 15-23 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T275 | 99-102 | Chemical | denotes | RAS | http://purl.obolibrary.org/obo/CHEBI_63620 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T66 | 123-133 | http://purl.obolibrary.org/obo/GO_0065007 | denotes | regulation |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T151 | 0-134 | Sentence | denotes | With regard to COVID-19, there are currently several clinical studies investigating the effects of RAS inhibition and ACE2 regulation. |
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T802 | 15-23 | SP_7 | denotes | COVID-19 |
| T803 | 118-122 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
| T804 | 123-133 | GO:0065007 | denotes | regulation |
| T76836 | 17-25 | SP_7 | denotes | VID-19, |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1083 | 118-122 | Gene | denotes | ACE2 | Gene:59272 |
| 1107 | 15-23 | Disease | denotes | COVID-19 | MESH:C000657245 |